Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart attack
MedTech
J&J's Abiomed pump reduces deaths after widowmaker heart attacks
It's Impella's first positive result from a randomized trial showing increases in six-month survival after acute STEMI and cardiogenic shock.
Conor Hale
Apr 8, 2024 12:12pm
Idorsia bags $350M upfront from Viatris for 2 late-phase assets
Feb 28, 2024 7:56am
CSL's largest ph. 3 trial ends in failure for heart attack drug
Feb 12, 2024 5:21am
QuidelOrtho faces Class I recall of heart attack blood tests
Jul 17, 2023 11:46am
Scientists pinpoint location of plaque ruptures
Jun 6, 2023 7:35am
Cleerly scores $192M for heart attack-predicting AI
Jul 25, 2022 11:51am
